C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 235/34 (2006.01) A61K 31/277 (2006.01) A61K 31/4164 (2006.01) A61K 31/44 (2006.01) A61K 31/4402 (2006.01) A61P 35/00 (2006.01) C07C 255/41 (2006.01) C07D 213/61 (2006.01) C07D 213/64 (2006.01) C07D 233/54 (2006.01)
Patent
CA 2648003
The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as inhibitors of Jak2/STAT3 pathways and downstream targets and inhibit the growth and survival of cancerous cell lines.
La présente invention concerne des composés et leur utilisation pour traiter des maladies de prolifération cellulaire telles que le cancer. Les composés de la présente invention affichent une activité importante comme inhibiteurs des voies Jak2/STAT3 et des cibles en aval et inhibent la croissance et la survie des lignées de cellules cancéreuses.
Conrad Charles
Fokt Izabela
Madden Timothy
Myers Jeffrey
Priebe Waldemar
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The Board Of Regents Of The University Of Texas System
LandOfFree
Orally bioavailable caffeic acid related anticancer drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orally bioavailable caffeic acid related anticancer drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally bioavailable caffeic acid related anticancer drugs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1812622